𝔖 Bobbio Scriptorium

✦ LIBER ✦

MH3 COST-EFFECTIVENESS OF METHYLPHENIDATE OROS FOR ATTENTION-DEFICIT/HYPERACTIVITY DISORDER (ADHD): AN EVALUATION FROM THE PERSPECTIVE OF THE UK NATIONAL HEALTH SERVICE (NHS)

✍ Scribed by M Schlander

Book ID: 119593033
Publisher: John Wiley and Sons
Year: 2004
Tongue: English
Weight: 56 KB
Volume: 7
Category: Article
ISSN: 1098-3015
DOI: 10.1016/s1098-3015(10)62116-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PMH9 ESTIMATING COST-EFFECTIVENESS OF CO

PMH9 ESTIMATING COST-EFFECTIVENESS OF CONCERTA OROS IN ATTENTIONDEFICIT/HYPERACTIVITY DISORDER (ADHD)—ADAPTING THE CANADIAN COORDINATING OFFICE FOR HEALTH TECHNOLOGY ASSESSMENT'S (CCOHTA) ECONOMIC MODEL OF METHYLPHENIDATE IMMEDIATE RELEASE VERSUS BEHAVIOURAL INTERVENTIONS FROM A PARENT'S PERSPECTIVE

✍ L Annemans; M Ingham 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 62 KB

EE8 COST EFFECTIVENESS OF CAPECITABINE I

EE8 COST EFFECTIVENESS OF CAPECITABINE IN COMBINATION WITH OXALIPLATIN (XELOX) COMPARED TO FOLFOX (5-FU, LV, OXALIPLATIN) FOR THE TREATMENT OF METASTATIC CARCINOMA OF THE COLON OR RECTUM (CRC) FROM A UK NATIONAL HEALTH SERVICE (NHS) PERSPECTIVE

✍ DR Millar; P Ducournau; A McDonald 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB